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Background: 2,5-hexanedione (2,5-HD) is the main neurotoxic metabolite of methyl-n-butyl ketone (MBK) and n-
hexane, and known to cause polyneuropathy. The aim of our study was to compare the urinary levels of 2,5-HD
between cases with cryptogenic polyneuropathy and the general Swedish population, and to elucidate the role of
certain external factors.
Methods: Morning urine samples were collected from 114 cases with cryptogenic polyneuropathy (77 men and 37
women) and 227 referents (110 men and 117 women) randomly selected from the population registry. None had
any current occupational exposure to n-hexane or MBK. The urine samples were analysed by a gas
chromatographic method based on acidic hydrolysis.
Results: Cases had statistically higher urinary levels of 2,5-HD (0.48 mg/L) than the general population (0.41 mg/L) and
men higher excretion than women (0.48 mg/L and 0.38 mg/L, respectively). There was no difference in 2,5-HD levels
between current smokers and non-smokers. Occupational exposure to xylene, alcohol consumption and ever exposed
to general anaesthesia were associated with lower excretion in men while for occupational exposure to nitrous oxide
in women higher excretion was seen. Higher excretion of 2,5 HD was inversely related to increasing age.
Conclusions: Significantly higher levels of urinary 2,5-HD were seen in men and cryptogenic polyneuropathy cases
seemingly unexposed to n-hexane. Hypothetically, this might be due to either differences in metabolic patterns or
some concealed exposure. The difference in means between cases and the general population is small and can
therefore not allow any firm conclusions of the causality, however.
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Polyneuropathy is a common disorder of the peripheral
nervous system in middle and late adulthood. The ae-
tiology is sometimes not clear, even after thorough medical
examination, and the polyneuropathy is then referred to as
cryptogenic. Studies suggest a role of occupational expo-
sures in the aetiology of cryptogenic polyneuropathy. We
have previously scrutinized clinical and neurophysiological* Correspondence: magnus.vrethem@lio.se
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reproduction in any medium, provided the orcharacteristics of patients with cryptogenic polyneuro-
pathy and investigated occupational determinants [1,2]. In
a case-referent study increased risks were found in men
for occupational exposure to sulphur dioxide, xylene,
methyl ethyl ketone, and herbicides along with solvent
exposure in leisure time, whereas in women increased
risks for occupational exposure to lead, nitrous oxide, and
insecticides were found [2].
The organic solvents methyl-n-buthyl ketone (MBK)
and n-hexane are well known to cause polyneuropathy
through the toxic metabolite 2,5-hexanedione (2,5-HD)
[3,4]. MBK has even greater neurotoxic potential than n-
hexane and furthermore another organic solvent, methyl-
ethyl-ketone (MEK) is known to potentiate the neurotoxicl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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extraction. N-hexane is also a compound derived from
cracking of petroleum. In Sweden the industrial use of
these solvents has decreased dramatically the latest de-
cades but n-hexane might still exist as contaminants in
other solvents and in petrol for cars. Previously n-hexane
was used in the extraction of vegetable oil for e.g. margar-
ine production with a threshold limit value of 1 mg/kg
applied by the National Food Agency in Sweden. As a
consequence, there are various routes of n-hexane expo-
sure to the human body (inhalation, dermal and oral) and
it is therefore difficult to estimate the total exposure in the
environment, because both occupational and life style
factors can contribute.
The urinary metabolite 2,5-HD can be measured in indi-
viduals occupationally exposed to n-hexane or MBK and
is regularly used for biological monitoring of workers
exposed. 2,5-HD can be measured as free metabolite or as
total 2,5-HD after acid hydrolysis. For monitoring of
workers total 2,5-HD has been frequently used worldwide,
but in 2011 the American Conference of Governmental
Industrial Hygienists (ACGIH) set up a biological expos-
ure index for free 2,5-HD in workers exposed to n-hexane
or MBK of 0.4 mg/L [7].
Urinary 2,5-HD has not only been detected in workers
with occupational exposure to n-hexane, but is also
found in low concentrations in the general population
(Table 1) [8-15]. The aim of this study was to compare
the excretion of 2,5-HD between cases of cryptogenic
polyneuropathy with no known occupational exposure
to n-hexane and the general population, and to elucidate
the influence of certain external factors.
Methods
Cases
The subjects in this study had previously been included
in a case-referent study, encompassing 164 cases of
cryptogenic polyneuropathy and 604 referents [2]. All
subjects lived in Östergötland or Jönköping counties inTable 1 Urinary levels of 2,5-hexanedione (2,5-HD) in general
Country n (men: women) 2,5-HD mean ± SD mg/L
Germany 8:4 0.45 ± 0.20
Italy 10 0.49 ± 0.14
Japan 55:0 1.47 ± 0.60
Japan 53:0 0.33 ± 0.47
Italy 26 0.56 ± ?
Italy 20:20 0.47 ± 0.21
Italy 22 0.44 ± 0.11
Italy 60:63 –
GC-MS Gas Chromatography with Mass-Selective detection, GC-FID Gas Chromatogr
Chromatography-Fluorescence detection.
1)after acid hydrolysis.the southeast of Sweden. Out of the 164 cases 114 (77
men and 37 women, mean age 70 years with a range of 43
to 88 years), could be included, 227 referents (110 men
and 117 women, mean age 64 years with a range of 46 to
85 years) out of the 300 randomly selected referents from
the same study were included for urine analysis of 2,5-HD
since 50 cases and 73 referents declined to participate.
The cases of cryptogenic polyneuropathy were diag-
nosed in three departments of neurology (University
Hospital in Linköping, Motala Hospital, and Ryhov
County Hospital in Jönköping). The databases of the
hospitals were searched for all outpatients between the
ages of 40 and 79 years with a diagnosis of polyneu-
ropathy. Two versions of the International Classification
of Diseases (ICD) were used in the time period of the
study, ICD-9 and ICD-10, in adopted Swedish versions.
The diagnosis of cryptogenic polyneuropathy corre-
sponds to the international classifications ICD-9 356.4,
356.9, 357.9 and ICD-10 G60.9, G61.9, G62.9, respect-
ively. All the medical records were re-examined by two
neurologists (JL, MV) to confirm the correct diagnoses.
Diagnosis of polyneuropathy was based on clinical
symptoms and findings and was defined as one or more
typical symptoms (distal paresthesias, numbness, neuro-
genic pain, distal weakness, loss of distal sweating) and
at least 2 of 3 clinical findings (distal deficit of sensation,
reduced distal muscle strength, and impaired or lost
deep tendon reflexes). We excluded patients with a
mainly demyelinating polyneuropathy to rule out Chronic
Inflammatory Demyelinating Polyneuropathy (CIDP) and
other inflammatory neuropathies. Patients under 40 years
of age were also excluded to avoid inclusion of hereditary
forms of polyneuropathy that had not yet been diagnosed.
Out of the 114 patients, 91 had been examined with nerve
conduction velocity to further establish a diagnosis of
axonal polyneuropathy and to exclude demyelinating
polyneuropathy. The following laboratory investigations
had to be performed and to be normal: haemoglobin,
serum glucose, cobalamin, folate, and thyroid function.populations
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ure, alcohol abuse, cobalamin deficiency, or other malig-
nant or systemic diseases known to be a possible cause
of polyneuropathy.
Exposure
Occupational and environmental exposure information
was received from a postal questionnaire used in the
case-referent study [2] and included questions regarding
other factors of potential interest i.e. food habits, alcohol
consumption and smoking habits not presented in the
previous study. Average alcohol consumption during
one month was categorized in the analysis as one group
with and one group without regularly alcohol intake
(wine, beer, spirits).
Urine samples
Both cases and referents were asked to cast a morning
urine sample, which was collected in a 10 ml polyethyl-
ene test tube. The test tube was frozen to −70 degrees
Celsius. The concentration of the metabolite 2,5-HD
was analysed by a gas chromatographic method based
on acid hydrolysis as previously described [16]. The pre-
cision of the method was 3.9% inter-assay and 0.7%
intra-assay and the detection limit was 0.1 mg/L. Five
urinary samples, all referents, showed values below the
detection limit (0.00, 0.03, 0.04, 0.08 and 0.09 mg/L) and
were after consideration included in the statistical ana-
lysis. The 2,5-HD levels were not adjusted to the urine
creatinine concentration since we aimed to compare our
results for the Swedish population to other populations
and most other studies were reported without such cor-
rection [8-15]. Moreover, as mentioned earlier, the urine
samples were collected as morning samples, hence less
sensitive to dilution.
Furthermore, a classification of various solvents with re-
gard to n-hexane containing solvents and thereby the
metabolic formation of 2,5-HD, was performed by two oc-
cupational physicians (B.P., M.T.) and one occupationalTable 2 Exposure variables included in different linear regres
Occupational exposure L
Model 1 Men Model 1 Women
Sulphur dioxide Lead Born
Xylene* Nitrous oxide* Curr
Methyl ethyl ketone Insecticides Fruit sev
Herbicides Vegetables
Solvents leisure time Meat se
Fish sev
Alcohol ≥2
1Methyl-n-buthyl ketone, petrol, Stoddard solvent, jet fuel, n-hexane. * p<0.05. Xyle
urinary excretion in men. Nitrous oxide exposure was associated with higher 2,5-HD
In all models case/referent status and year of birth was included and analysed sepahygienist (P.S.) independently. Organic solvents forming
2,5-HD were merged into a new variable i.e. methyl-
n-buthyl ketone, petrol, Stoddard solvent, jet fuel and n-
hexane (Table 2).
Ethical approval
The ethics committee at the Faculty of Health Sciences
at Linköping University has approved the study.
Statistical methods
The Kolmogorov-Smirnov test showed that the urinary
2,5-HD levels could be regarded as normally distributed
(p<0.1) and thus the student’s t-test could be applied in
the univariate analyses performed to compare the diffe-
rences in mean urinary 2,5-HD levels between cases and
referents. A p-value of <0.05 was considered statistically
significant. In order to investigate the influence of
various factors on the urinary excretion of 2,5-HD we
applied different linear regression models. Included in
all models were case-referent status (to have crypto-
genic polyneuropathy or not) and year of birth. All these
linear regression analyses were performed separately for
men and women. Analyses were performed using Stata
(Statistical Software, release 8.0; Stata Corp., College
Station, Tex., USA).
Results
Cases had statistically significant higher excretion of 2,5-
HD in urine than referents (mean 0.48 mg/L compared
to 0.41 mg/L) and men had statistically significant higher
excretion than women (mean 0.48 mg/L compared to
0.38 mg/L) (Table 3, Figure 1). Excretion of 2,5-HD was
higher in men compared to women within both cases
and referents, however only statistically significant for
the larger group of referents (Table 3). Also the urinary
levels were higher for cases than for referents of both
sexes although not statistically significant (Table 3). The
excretion of 2,5-HD was inversely related to increasing
age only for male referents (Figure 2). There was nosion models with respect to urinary 2,5-HD levels
ife style Solvent exposure
Model 2 Model 3
in Sweden 2,5-hexanedione solvents1
ent smoking Nitrous oxide occupationally*for women
eral times/week Solvents in leisure time




ne, alcohol consumption and anaesthesia was associated with lower 2,5-HD
urinary excretion in women.
rately by sex.
Table 3 Urinary excretion of 2,5-hexanedione (2,5-HD) in mg/L related to sex and case/referent status, age distribution
and numbers of subjects included
Status n Mean age (range) 2,5-HD±SD p-value Sex n 2,5-HD±SD p-value
Case 114 70 (43–88) 0.48±0.28 0.01 Men 77 0.51±0.29 0.08
Women 37 0.42±0.23
Referent 227 64 (46–85) 0.41±0.25 Men 110 0.46±0.27 0.004
Women 117 0.36±0.23
Sex n Mean age (range) 2,5-HD±SD p-value Status n 2,5-HD±SD p-value
Men 187 66 (47–88) 0.48±0.28 0.0002 Case 77 0.51±0.29 0.22
Referent 110 0.46±0.27
Women 154 66 (43–86) 0.38±0.23 Case 37 0.42±0.23 0.21
Referent 117 0.36±0.23
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between current smokers and non-smokers. No men re-
ported occupational exposure to nitrous oxide.
In all the linear regression analyses case/referent status
and year of birth were statistically significant variables
for men, but not for women, with higher urinary 2,5-HD
excretion for male cases and younger men.
Occupational exposures identified with logistic odds
ratios >3.50, in the previous case-referent study [2] were
included in the first model (i.e. for men: occupational ex-
posure to sulphur dioxide, xylene, methyl ethyl ketone,
herbicides and also solvent exposure in leisure time and
for women: occupational exposure to lead, nitrous oxide
and insecticides) (Table 2). In this model only occu-
pational exposure to xylene in men was significant
in relation to lower urinary 2,5-HD excretion levelsFigure 1 Urinary levels of 2,5-hexanedione (2,5-HD) in mg/L, mean an
and women.(p= 0.03; regression coefficient −0.30; 95% confidence
interval (CI) -0.57 to −0.03). For women only occupa-
tional exposure to nitrous oxide (p<0.05; regression
coefficient 0.32; 95% CI 0.01 to 0.64) was significant,
but with higher urinary 2,5-HD levels among the occu-
pationally exposed.
Attributes in the second model included: born in
Sweden, current smoking, food habits and alcohol con-
sumption (Table 2). Among these life style factors in
model 2 only alcohol consumption (p=0.01; regression
coefficient −0.11; 95% CI −0.20 to −0.03) was statisti-
cally significant for men, with lower excretion among
men with more frequent drinking. None of the variables
in model 2 showed any significant results for women.
Included in the third model were various occupational
solvent exposures, occupational exposure to nitrous oxide,d 95% confidence interval, in cases and referents and men
Figure 2 Urinary levels of 2,5-hexanedione (2,5-HD) in mg/L in men and women, and cases and referents, separately, in relation to age.
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surgery performed under general anaesthesia (Table 2).
General anaesthesia (p=0.01; regression coefficient −0.11;
95% CI −0.19 to −0.02) was significantly associated with
lower urinary 2,5-HD levels in men. In women higher
excretion of urinary 2,5-HD was seen in those exposed to
nitrous oxide (p<0.05; regression coefficient 0.33; 95% CI
0.01 to 0.65). Organic solvents metabolised to 2.5-HD
showed no statistic significance in men or women.
Discussion
Numerous studies have shown that 2,5-HD is a neurotoxic
metabolite and causes polyneuropathy in occupational
exposure to n-hexane [17,18]. Most studies, however, have
been performed in industries with occupationally expo-
sure to n-hexane [19-21] and less is known about the im-
portance for development of neuropathy in presumably
occupationally unexposed individuals.
In our study men with cryptogenic polyneuropathy had
higher urinary excretion of 2,5-HD. Men showed consis-
tently higher excretion than women in all analyses. We
also found higher excretion of 2,5-HD inversely related to
increasing age. Levels of urinary 2,5-HD in the general
population were in accordance to previous published
results, especially in European populations (Table 1). Ex-
posure to xylene, alcohol, and general anaesthesia were as-
sociated with lower excretion in men, but for occupational
exposure to nitrous oxide in women a higher excretion
was seen. Xylene, alcohol and drugs used for general
anaesthesia are all metabolised in the liver giving rise to a
possible hepatic enzyme induction affecting the metabo-
lism of n-hexane. In contrast, nitrous oxide is an inorganic
gas with minimal or no metabolism in human tissues [4].These facts might support the finding of reverse results
between certain exposures and the urinary excretion. The
differences in urinary 2,5-HD excretion between the sexes
can also reflect gender variations in exposure.
Cases had no current occupational exposure to n-hexane,
but micro exposure in the environment could not be ex-
cluded. If existing randomly among cases and referents,
however, this would probably not explain the higher excre-
tion in cases. We also do not have data on men having dif-
ferent micro exposure to n-hexane than women explaining
the difference in urinary 2,5-HD excretion between the
sexes. Another hypothesis is lipid peroxidation within the
body resulting in formation of 2,5-HD, but no information
on different metabolism between sexes, or for cases with
polyneuropathy, is available.
The formation of 2,5-HD from n-hexane involves
several genes and an association between the CYP2E1
gene might increase the susceptibility to develop n-hexane
induced polyneuropathy [22]. Among our cases we found
only two individuals with the gene expression CYP2E1
and we had no information about this gene among the
referents. Therefore, we excluded these two cases and it
did not change the mean values of 2.5-HD. Another gene
involved in n-hexane metabolism is GSTT1. In a previous
study, an increased risk for cryptogenic polyneuropathy
was found in smokers with the gene GSTT1 null [23].
Furthermore, urinary 2,5-HD excretion is increased in
smokers versus non-smokers [24]. In our study, however,
we did not find any differences in 2,5-HD levels in urine
between smokers and non-smokers.
In Parkinson’s disease poor metabolization of n-hexane
has been proposed as a risk factor for the disease because
of lower urinary 2,5-HD levels compared with controls
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togenic polyneuropathy had higher urinary 2,5-HD than
the general population. Corroborating our results, how-
ever, the 2,5-HD levels inversely correlated to increasing
age [24].
From the methodological point of view, even if ACGIH
nowadays considers “free” 2,5-HD as biological exposure
index for workers exposed to n-hexane, we had decided to
use total 2,5-HD. As mentioned earlier and to allow
comparisons with urinary concentrations, almost all
previous studies considering concentrations of 2,5-HD
in non-occupationally exposed populations have used
total 2,5-HD. Moreover, when the study was performed
ACGIH was still using total 2,5-HD as a biological ex-
posure index in workers exposed to n-hexane and MBK
[25]. The choice of “total” or “free” 2,5-HD as index of
exposure is under debate and still controversial [26].
Conclusions
To our knowledge this is the first study investigating uri-
nary 2,5-HD levels in cases with cryptogenic polyneurop-
athy compared to the general population. We found
significantly higher levels for the cases. Even if the differ-
ences in 2,5-HD excretion were small our study suggests
that some external exposures, along with sex and age,
could influence the excretion of 2,5-HD in subjects occu-
pationally unexposed to n-hexane and MBK. On the other
hand, it might also reflect a different metabolic pattern
among the cases compared to the general population. The
slight differences do not allow any conclusions about the
aetiological role even though n-hexane exposure is a well-
known cause of polyneuropathy.
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